Search

everythinglearnresearchcommunity

for

Search:↓

Skin reactions from cancer treatments might predict how well the treatments work.

People undergoing chemotherapy need better support and information to cope with hair loss.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

The symposium showed that stem cells are key for understanding and treating skin diseases and for developing new skin models and therapies.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

The document concludes that recent studies help tell apart desmoplastic trichoepitheliomas from other skin tumors, but more research is needed for clear differentiation.

Panitumumab can cause excessive ear hair growth.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

We need better ways to test and understand SARMs to make safer and more effective treatments.